Mindfulness and Behavior Change to Reduce Cardiovascular Disease Risk in Older People with HIV
正念和行为改变可降低老年艾滋病毒感染者的心血管疾病风险
基本信息
- 批准号:10762220
- 负责人:
- 金额:$ 19.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-05 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acute myocardial infarctionAddressAffectAlcohol consumptionAlcoholsAmazeAtherosclerosisAutomobile DrivingBehavior TherapyBehavioralBehavioral MechanismsBehavioral MedicineBehavioral SciencesBenchmarkingBiologicalBiological MarkersBlood PressureBreathingCardiologyCardiovascular DiseasesCardiovascular systemCellular PhoneChronicClinicalClinical TrialsCommunicable DiseasesDiseaseDoseEducationElderlyElementsEnvironmentExerciseFeedbackFoundationsFunctional disorderGeneral HospitalsGeneral PopulationGoalsHIVHIV/AIDSHealthHealth behaviorHeartHeart failureImmuneImmune responseInflammationInflammatoryInformal Social ControlInstitutionIntegrative MedicineInterdisciplinary StudyInterventionInterviewIschemic StrokeLanguageLicensingLinkLongevityMassachusettsMediatingMental disordersMentorsMentorshipMethodsMindModalityModelingMovementNational Heart, Lung, and Blood InstitutePatient Self-ReportPersonal SatisfactionPersonsPhaseProtocols documentationPsychologistPsychologyPublicationsPublishingQualitative MethodsRandomized, Controlled TrialsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch PriorityRiskRisk BehaviorsRisk ReductionSamplingSelf EfficacyStressStructureSymptomsTextText MessagingTobacco smoking behaviorTrainingTraining ProgramsUnhealthy DietUnited StatesWomanWorkacceptability and feasibilityagedbehavior changecardiovascular disorder riskcomorbiditydiabetes prevention programeHealtheffective interventionefficacy trialendothelial dysfunctionevidence baseexperiencehealth managementimpaired glucose toleranceimprovedinnovationinterestintervention refinementmedical schoolsmeetingsmindfulnessmindfulness interventionmindfulness-based stress reductionmobile computingmultidisciplinarynovelphysical inactivitypilot testprogramspsychologicpsychological distressskillssubstance usesystemic inflammatory responsetext messaging interventiontherapy developmenttreatment as usualtrial designuptake
项目摘要
PROJECT SUMMARY
In this K23 proposal, I outline a comprehensive five-year training program that will prepare me for the transition
to an independent, R01 level investigator capable of developing novel, feasible, and scalable integrative
behavioral interventions to reduce psychological and cardiovascular disease (CVD) risk in older people with
HIV (OPWH). To achieve this goal, my training objectives are to: 1.) develop expertise in mindfulness and
behavior change for CVD risk reduction; 2.) gain experience in randomized controlled trial (RCT) design and
implementation among OPWH; and 3.) develop proficiency in inflammation biomarker research to better my
understanding of the HIV-CVD pathophysiology. In this application, I propose a significant and innovative
research strategy, an amazing interdisciplinary mentorship team, and comprehensive didactic plan to support
these goals. Background: OPWH are disproportionately impacted by CVD attributable to chronic HIV immune
dysregulation and resulting inflammation. Systemic inflammation is exacerbated by psychological distress via
activating the immune response and driving proinflammatory CVD risk behaviors. There is promising evidence
to suggest that mindfulness could be an effective intervention to reduce psychological distress and support
behaviorally- and inflammatory-mediated CVD risk reduction. Specific Aims and Research Design: I propose
to refine and synthesize mindfulness and behavior change content from evidence-based protocols
(mindfulness-based stress reduction and diabetes prevention program) to develop and pilot test a new text
message-enhanced intervention called “One Mind One Heart” (OM-OH) using feedback from semi-structured
interviews with OPWH in psychological distress (N=20), and my multidisciplinary mentorship team (Aim 1).
Next, I will explore, via an open pilot (N=5) with exit interviews and pre-post self-report assessments, the initial
acceptability of OM-OH and further refine OM-OH as needed (Aim 2). Finally, I will conduct a pilot randomized
controlled trial (RCT; N=50) to a.) evaluate benchmarks of feasibility and acceptability of study methods and
refined OM-OH compared to enhanced usual care, and b.) investigate potential for effects on psychological
distress, inflammation, and behavioral CVD risk (Aim 3). Findings will provide the foundation for an R01
application to conduct an efficacy trial of OM-OH to reduce inflammatory-mediated CVD risk among OPWH.
Training and Mentorship: My training plan will be led by my co-primary mentors Drs. Conall O’Cleirigh and
Gloria Yeh, both renowned researchers focused on intervention development and clinical trials for HIV and
cardiovascular disease, respectively. I will also be supported by a.) a team of expert co-mentors and
collaborators, b.) a rich institutional environment at Massachusetts General Hospital and Harvard Medical
School, and c.) targeted coursework, scientific meetings, seminars, and planned publications. Relevance to
NHLBI: This K23 is in line with the published research priorities of the NHLBI HIV/AIDS program to address
HIV-related cardiovascular comorbidities.
项目摘要
在此K23提案中,我概述了一项全面的五年培训计划,该计划将使我为过渡做好准备
对于独立的R01级研究者,能够开发新颖,可行和可扩展的整合
降低心理和心血管疾病(CVD)风险的行为干预措施
艾滋病毒(OPWH)。为了实现这一目标,我的培训目标是:1。)在正念和
CVD风险降低的行为改变; 2.)在随机对照试验(RCT)设计和
OPWH之间的实施; 3.)炎症生物标志物研究的发展水平,以改善我
了解HIV-CVD病理生理学。在此应用程序中,我提出了一个重要而创新的
研究策略,一个了不起的跨学科思想团队以及支持的全面教学计划
这些目标。背景:OPWH受到可归因于慢性HIV免疫的CVD的不成比例的影响
失调和导致的感染。心理困扰通过
激活免疫响应和驱动促炎CVD风险行为。有希望的证据
暗示正念可能是减少心理困扰和支持的有效干预措施
行为和炎症介导的CVD风险降低。具体目的和研究设计:我提出
完善和综合正念和行为从基于证据的协议中更改内容
(基于正念的压力减轻和预防糖尿病计划)开发和试点测试新文本
消息增强的干预措施称为“一颗心脏一颗心”(OM-OH),使用半结构化的反馈
在心理困扰(n = 20)和我的多学科心态团队(AIM 1)中对OPWH的访谈。
下一
OM-OH的可接受性,并根据需要进一步完善OM-OH(AIM 2)。最后,我将进行一个随机的飞行员
对照试验(RCT; n = 50)至a。)评估研究方法的可行性和可接受性的基准
与增强的通常护理相比,精致的OM-OH和b。)调查对心理影响的潜力
困扰,炎症和行为CVD风险(AIM 3)。调查结果将为R01提供基础
应用OM-OH进行效率试验以减少OPWH中炎症介导的CVD风险。
培训和指导:我的培训计划将由我的联合主要导师DRS领导。 Conall O'Clairigh和
格洛里亚·耶(Gloria Yeh)都是著名的研究人员,专注于干预开发和艾滋病毒和临床试验
心血管疾病分别。我还将得到a的支持。
合作者,b。)马萨诸塞州综合医院和哈佛医学的丰富机构环境
学校和c。)针对的课程,科学会议,半手级和计划的出版物。与
NHLBI:此K23符合NHLBI HIV/AIDS计划的已发表的研究优先事项
与HIV相关的心血管合并症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacklyn Donna Foley其他文献
Jacklyn Donna Foley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Subdural Hematoma Outcomes in a Population (SD HOP) Study
硬膜下血肿人群 (SD HOP) 研究结果
- 批准号:
10591861 - 财政年份:2023
- 资助金额:
$ 19.59万 - 项目类别:
Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality
查明美国全国心血管疾病死亡率停滞不前的原因
- 批准号:
10585800 - 财政年份:2023
- 资助金额:
$ 19.59万 - 项目类别:
Microphysiological Systems to Study Hypoxic Cardiac Injury
研究缺氧性心脏损伤的微生理系统
- 批准号:
10591258 - 财政年份:2023
- 资助金额:
$ 19.59万 - 项目类别:
Merging artificial intelligence (AI) and pharmacometrics to elucidate gene-drug interactions linked to clopidogrel responsiveness in Caribbean Hispanic patients
融合人工智能 (AI) 和药理学,阐明与加勒比西班牙裔患者氯吡格雷反应相关的基因药物相互作用
- 批准号:
10626448 - 财政年份:2023
- 资助金额:
$ 19.59万 - 项目类别: